Clarametyx Home Revenue and Competitors
Estimated Revenue & Valuation
- Clarametyx Home's estimated annual revenue is currently $1.8M per year.
- Clarametyx Home's estimated revenue per employee is $91,000
Employee Data
- Clarametyx Home has 20 Employees.
- Clarametyx Home grew their employee count by 5% last year.
Clarametyx Home's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder & Chief Scientific Officer | Reveal Email/Phone |
2 | Co-founder & Board Co-Chair | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP, Clinical Operations | Reveal Email/Phone |
5 | Director Clinical Development and Portfolio Strategy | Reveal Email/Phone |
6 | Co-founder & Chief Scientific Officer | Reveal Email/Phone |
7 | Director, Project Operations | Reveal Email/Phone |
8 | Chief Operating Officer | Reveal Email/Phone |
9 | Operations Program Manager | Reveal Email/Phone |
10 | Scientific Co-Founder & Scientific Advisory Board Co-Chair | Reveal Email/Phone |
Clarametyx Home Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0M | 1 | -67% | $3M | N/A |
#2 | $379.7M | 0 | N/A | $30.5M | N/A |
#3 | $6.2M | 55 | -4% | $3.4M | N/A |
#4 | $0.6M | 9 | -10% | N/A | N/A |
#5 | $62.7M | 380 | -29% | $609.1M | N/A |
#6 | $0M | 2 | 0% | $10M | N/A |
#7 | $56.2M | 346 | -7% | N/A | N/A |
#8 | $11.4M | 88 | N/A | N/A | N/A |
#9 | $94.6M | 582 | 5% | N/A | N/A |
#10 | $3.8M | 37 | -7% | N/A | N/A |
What Is Clarametyx Home?
Clarametyx Biosciences Inc. is a preclinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
keywords:N/AN/A
Total Funding
20
Number of Employees
$1.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clarametyx Home News
2022-03-30 - CARB-X Awards Clarametyx Biosciences $3.89 Million in ...
(Clarametyx), a preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter serious infections...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A |
#2 | $2.1M | 20 | 11% | N/A |
#3 | $3.5M | 20 | 5% | N/A |
#4 | $2M | 20 | -5% | N/A |
#5 | $3.5M | 20 | 5% | N/A |